Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3851292 | American Journal of Kidney Diseases | 2007 | 8 Pages |
Abstract
Low- and full-intensity anticoagulation use in HD patients is associated with a significant bleeding risk, which has to be balanced against any potential benefit of therapy. This has to be considered carefully when prescribing warfarin to HD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Meghan J. BSc, Deborah MD, MSc, Rachel M. MD,